January 15, 2025

FDA to Revoke Red No. 3

Red No. 3 is found in many popular food items, including Pop Tarts, Dole Fruit Packs, Double Bubble Gum, Peeps, and more.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Phase 3 Results: Tisotumab Vedotin vs Chemotherapy

Study evaluates tisotumab vedotin for recurrent cervical cancer in phase 3.

Conexiant

January 13, 2025

Boosting Primary Care: Medical School Strategies

"It’s not the medical schools that are the problem; it’s the job. The job is too toxic.”

KFF Health News

January 06, 2025

Medical Editors Sound Alarm on Fake Journals

"Particularly vulnerable authors are those who are early in their careers, lack experience and adequate mentorship, and face pressure to publish" — top medical journal editors expose how predatory publishers exploit researchers.

Conexiant

December 20, 2024

Advanced Breast Cancer Cases Rising in U.S.

The incidence of late-stage, invasive breast cancer has risen significantly across all age groups and ethnicities in the U.S. from 2004 to 2021, emphasizing the critical need for enhanced breast cancer screening and early detection.

Reuters

December 20, 2024

Is Surgery Necessary for Low-Risk DCIS?

“If these results hold up over time, most patients who have this type of low-risk disease will have the option of avoiding invasive treatments."

Reuters

December 06, 2023

'Game-Changer’ Intervention for Ovarian Cancer Prevention

Gynecologic oncologist Rebecca Stone and colleagues at Johns Hopkins are leading the way in salpingectomy — a quick, low-risk surgical intervention that can significantly reduce the risk of ovarian cancer.

Johns Hopkins Medicine

December 11, 2023

Expert Point of View: Bradley J. Monk, MD, FACS, FACOG

Discover how immune checkpoint inhibitors are transforming the landscape of cervical cancer treatment, with significant implications for patient outcomes and clinical decision-making.

The ASCO Post